By Sneha S K April 2 (Reuters) - Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in ...

March 30 (Reuters) - Viridian Therapeutics said on Monday its experimental drug met the main goal in late-stage study, when ...

Immunovant’s first-generation FcRn inhibitor flunked a pair of phase 3 eye disease trials, appearing to end the last hopes of ...

The data did not meet investor expectations, and could bring “fierce investor debate on commercial feasibility,” according to ...

A subcutaneous monoclonal antibody induced greater reductions in proptosis at 24 weeks than placebo for people with active ...

Despite hitting its primary endpoint, Viridian’s thyroid eye disease antibody failed to ease eye bulging to the degree that ...

The Roivant group company said that treatment with batoclimab had shown some improvement in the eye bulging (proptosis) ...

Please provide your email address to receive an email when new articles are posted on . Women with thyroid dysfunction before and during pregnancy had a 2.68-fold higher risk for having a child ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." The thyroid is an incredibly important gland. Located at the front of the neck, it plays a key role in ...

Thyroid eye disease can cause eye pain, dryness, and eyelids that do not fully close. These symptoms can disrupt sleep. When your eyes stay partly open at night, light and dryness can make it harder ...